(Q46823637)

25 December 2017

title

Combination polypharmacy for cardiovascular disease prevention in men: a decision analysis and cost-effectiveness model (English)

1 reference

25 December 2017

main subject

cardiovascular disease

1 reference

1 reference

1 reference

1

1 reference

25 December 2017

William Grobman

series ordinal

2

object named as

William A Grobman

1 reference

25 December 2017

Philip Greenland

series ordinal

3

object named as

Philip Greenland

1 reference

25 December 2017

publication date

1 January 2008

1 reference

25 December 2017

published in

Preventive Cardiology

1 reference

25 December 2017

volume

11

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

36-41

1 reference

25 December 2017

World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

A strategy to reduce cardiovascular disease by more than 80%

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Combination pharmacotherapy for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Trends in validated cases of fatal and nonfatal stroke, stroke classification, and risk factors in southeastern New England, 1980 to 1991 : data from the Pawtucket Heart Health Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Incidence and occurrence of total (first-ever and recurrent) stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Life expectancies among survivors of acute cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Incidence and characteristics of angioedema associated with enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Efficacy and long-term adverse effect pattern of lovastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Cerivastatin and reports of fatal rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1520-037X.2007.06423.X

10.1111/J.1520-037X.2007.06423.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017